Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

Healthcare takes the top spot among Keypath Education’s offerings, helps boost quarter revenue

  • In News
  • October 26, 2022
  • Alinda Gupta
Healthcare takes the top spot among Keypath Education’s offerings, helps boost quarter revenue

Covid-19 revealed the ugly cracks in the global healthcare system, unveiling a need for better tech and more workers. Thankfully, many students have taken it upon themselves to be the flag bearers of change as EdTech company Keypath Education International (ASX: KED) reports a revenue growth of 17% on Q1FY22 within its healthcare offerings. 

Overall, the Company reported a Q1 FY23 revenue of $49.2 million (US$31.4 million), which is 3.4% higher than Q1 FY22. In FY22, the Company’s quarter-on-quarter revenue comparability has been impacted in Australia by the COVID-related increase in enrollments due to lockdowns earlier in the year and by the expected softening of enrollments in some programs from mature vintages. 

For Keypath, the upcoming year is a “transition year” that will set itself in the position for growth. As international students return (pushing enrolments to over 100k), online education takes off and demand for certain courses picks up, Keypath has plenty to benefit from. In fact, it added two new partners and seven new programs in its nursing, health and social services verticals in Q1 FY23.

Keypath’s Founder and CEO, Steve Fireng, said “Our significant progress in global Healthcare OPM continues with our market leading Healthcare platform delivering outstanding outcomes for our partners, students and society more broadly as we work to close the significant shortages of healthcare workers globally. We continue to transition our investments to vintages and programs where we see the strongest demand and, as expected, contribution margin and adjusted EBITDA have been impacted by this.” 

Keypath is a global EdTech company founded in 2014, geared towards the online program management (OPM) market. It boasts over 40 university partners, and aims to deliver career-relevant, technology-enabled online higher education programs. 

As of September 30, 2022, its program count stands at 185, which represents an increase of seven programs from June 30, 2022. The seven programs added in the quarter came from the North American region, with five coming from the nursing vertical and two coming from the health and social services vertical.

Fireng added, “We have already closed 18 programs from our FY24 vintage of which 17 are in Healthcare. With the unprecedented demand we are converting into our largest ever partner and program pipeline, Keypath is well positioned across the globe to expand its technology and services to continue to help universities provide quality access to education in a digital environment including by continuing to grow our programs in Southeast Asia.”

The Company will continue to invest into newer vintages comprising programs with improved growth, unit economics and returns profiles. It is using the strong growth performance of its FY21 vintage programs as its benchmark, comparing it to Keypath’s earlier “pre-KeypathEDGE” vintages. The Company is counting on the new programs to usher in profitability and close the healthcare workers gap. 

It is confident in achieving its guidance for FY23, which comprises revenue of US$125 million – US$130 million ($195 million to $203 million) on a constant currency basis. Moreover, it plans on increasing its online footprint from 2% penetration in FY22 to 5% come 2025. Finally, the Company will make its attempt at a Southeast Asia market expansion, starting with Malaysia and Singapore. Can it disrupt the healthcare education systems of countries with the most successful healthcare institutions in the world? 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.